ICM Val d'Aurelle

Futó vizsgálatok

• Még nem toboroz

  Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

  NCT07637851· 1/2. fázis· Forrás

• Toboroz

  Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)

  NCT07098182· Forrás

• Toboroz

  Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

  NCT06476184· 3. fázis· Forrás

• Toboroz

  Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

  NCT06027632· Forrás

• Toboroz

  PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

  NCT05581121· 3. fázis· Forrás

• Toboroz

  Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer

  NCT04823923· Forrás

• Toboroz

  Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

  NCT04698785· 2. fázis· Forrás

• Fut, nem toboroz

  Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients

  NCT03870919· Forrás

• Fut, nem toboroz

  Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy

  NCT03908788· Forrás

• Fut, nem toboroz

  Two Chemotherapy Regimens Plus or Minus Bevacizumab

  NCT03351296· 2. fázis· Forrás

• Toboroz

  Establishment of a Prospective Clinical-biological Database

  NCT04458792· Forrás

• Fut, nem toboroz

  National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

  NCT02867033· Forrás

• Fut, nem toboroz

  Development of a Clinical and Biological Database in Rectum Cancer

  NCT04006951· Forrás

• Fut, nem toboroz

  Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

  NCT02089100· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Petefészekrák3 toboroz
• Gyermekkori daganatok2 toboroz
• Szarkóma2 toboroz
• Krónikus vesebetegség1 toboroz
• Méhnyakrák1 toboroz
• Vastagbélrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

  NCT05625087· 2. fázis· Forrás

• Leállították

  EO4010 in Previously Treated Metastatic Colorectal Carcinoma

  NCT05589597· 1/2. fázis· Forrás

• Leállították

  SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

  NCT05010850· Forrás

• Toboroz

  Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT

  NCT04602377· 2. fázis· Forrás

• Lezárult

  Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

  NCT04799249· 3. fázis· Forrás

• Lezárult

  Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

  NCT04744831· 2. fázis· Forrás

• Lezárult

  A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

  NCT04322539· 3. fázis· Forrás

• Lezárult

  Memory Perception Assessment in Central/Non-central Nervous System Cancers

  NCT03975959· Forrás

• Lezárult

  UTOLA: UTerin OLAparib

  NCT03745950· 2. fázis· Forrás

• Lezárult

  Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

  NCT03598270· 3. fázis· Forrás

• Lezárult

  Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer

  NCT03579394· Forrás

• Lezárult

  Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

  NCT03556839· 3. fázis· Forrás

• Lezárult

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· 3. fázis· Forrás

• Lezárult

  Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer

  NCT03249142· 1/2. fázis· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· Forrás

• Lezárult

  Development of Clinical and Biological Database in Colorectal Cancer

  NCT04186117· Forrás

• Lezárult

  PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer

  NCT02359968· 2. fázis· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Forrás